Endogenous secretory receptor for advanced glycation endproducts as a novel prognostic marker in chondrosarcoma (Q33284424)

25 July 2017

Endogenous secretory receptor for advanced glycation endproducts as a novel prognostic marker in chondrosarcoma (English)

1 reference

25 July 2017

0 references

Akihiko Takeuchi

1

0 references

Hiroyuki Tsuchiya

10

object named as

Hiroyuki Tsuchiya

1 reference

25 July 2017

Yasuhiko Yamamoto

2

1 reference

25 July 2017

Koichi Tsuneyama

3

1 reference

25 July 2017

Chunmei Cheng

4

1 reference

25 July 2017

Hideto Yonekura

5

1 reference

25 July 2017

Takuo Watanabe

6

1 reference

25 July 2017

Katsuji Shimizu

7

1 reference

25 July 2017

Katsuro Tomita

8

1 reference

25 July 2017

Hiroshi Yamamoto

9

1 reference

25 July 2017

language of work or name

English

0 references

publication date

1 June 2007

1 reference

25 July 2017

1 reference

25 July 2017

109

1 reference

25 July 2017

12

1 reference

25 July 2017

2532-2540

1 reference

Low risk of recurrence of enchondroma and low-grade chondrosarcoma in extremities. 80 patients followed for 2-25 years.

25 July 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22731

7 January 2021

Prognostic factors in chondrosarcoma of bone: a clinicopathologic analysis with emphasis on histologic grading

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22731

7 January 2021

The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22731

7 January 2021

Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22731

7 January 2021

RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22731

7 January 2021

The structure of S100A12 in a hexameric form and its proposed role in receptor signalling

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22731

7 January 2021

Amyloid-beta peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22731

7 January 2021

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22731

7 January 2021

The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22731

7 January 2021

Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22731

7 January 2021

The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22731

7 January 2021

HMG-1 as a late mediator of endotoxin lethality in mice

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22731

7 January 2021

High mobility group 1 B-box mediates activation of human endothelium

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22731

7 January 2021

Expression of receptors for advanced glycation end-products (RAGE) is closely associated with the invasive and metastatic activity of gastric cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22731

7 January 2021

Expression analysis of S100 proteins and RAGE in human tumors using tissue microarrays

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22731

7 January 2021

Calcium-binding proteins S100A8 and S100A9 as novel diagnostic markers in human prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22731

7 January 2021

Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22731

7 January 2021

Expression profiling of endogenous secretory receptor for advanced glycation end products in human organs

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22731

7 January 2021

Improved 1-h rapid immunostaining method using intermittent microwave irradiation: practicability based on 5 years application in Toyama Medical and Pharmaceutical University Hospital

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22731

7 January 2021

Clinical relevance of Ki-67 expression in bone tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22731

7 January 2021

Development of an ELISA for esRAGE and its application to type 1 diabetic patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22731

7 January 2021

Prognostic factors in chondrosarcoma: a comparative study of cellular DNA content and clinicopathologic features

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22731

7 January 2021

Prognostic significance of Ki67 (MIB1) proliferation index and p53 over-expression in chondrosarcomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22731

7 January 2021

Altered p53 is associated with aggressive behavior of chondrosarcoma: a long term follow-up study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22731

7 January 2021

Telomerase reverse transcriptase subunit expression is associated with chondrosarcoma malignancy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22731

7 January 2021

Cytogenetics as a tool in the histologic subclassification of chondrosarcomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22731

7 January 2021

Bone remodelling in the presence of chondrosarcoma: histomorphometry

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22731

7 January 2021

Borderline chondrosarcoma of long and flat bones

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22731

7 January 2021

Identifiers

DOI

10.1002/CNCR.22731

1 reference

25 July 2017

1 reference